HUTCHMED (China) Limited (HCM)
NASDAQ: HCM · IEX Real-Time Price · USD
17.22
-0.34 (-1.94%)
Jul 2, 2024, 4:30 PM EDT - Market closed
HUTCHMED (China) Market Cap
HUTCHMED (China) has a market cap or net worth of $3.00 billion as of July 2, 2024. Its market cap has increased by 55.62% in one year.
Market Cap
3.00B
Enterprise Value
2.20B
1-Year Change
55.62%
Ranking
Category
Stock Price
$17.22
Market Cap Chart
Since March 17, 2016, HUTCHMED (China)'s market cap has increased from $1.60B to $3.00B, an increase of 87.90%. That is a compound annual growth rate of 7.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 3.00B | -4.35% |
| Dec 29, 2023 | 3.14B | 22.75% |
| Dec 30, 2022 | 2.56B | -50.05% |
| Dec 31, 2021 | 5.12B | 19.79% |
| Dec 31, 2020 | 4.27B | 27.79% |
| Dec 31, 2019 | 3.34B | 8.92% |
| Dec 31, 2018 | 3.07B | -35.89% |
| Dec 29, 2017 | 4.79B | 195.91% |
| Dec 30, 2016 | 1.62B | 1.27% |
| Mar 17, 2016 | 1.60B | - |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Olink Holding AB (publ) | 3.17B |
| PROCEPT BioRobotics | 3.14B |
| Biohaven Pharmaceutical Holding Company | 3.06B |
| Surgery Partners | 3.02B |
| Amedisys | 3.00B |
| LivaNova | 2.97B |
| Arcellx | 2.95B |
| Xenon Pharmaceuticals | 2.94B |